Your browser doesn't support javascript.
loading
Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers.
Hogenson, Tara L; Xie, Hao; Phillips, William J; Toruner, Merih D; Li, Jenny J; Horn, Isaac P; Kennedy, Devin J; Almada, Luciana L; Marks, David L; Carr, Ryan M; Toruner, Murat; Sigafoos, Ashley N; Koenig-Kappes, Amanda N; Olson, Rachel Lo; Tolosa, Ezequiel J; Zhang, Cheng; Li, Hu; Doles, Jason D; Bleeker, Jonathan; Barrett, Michael T; Boyum, James H; Kipp, Benjamin R; Mahipal, Amit; Hubbard, Joleen M; Scheffler Hanson, Temperance J; Petersen, Gloria M; Dasari, Surendra; Oberg, Ann L; Truty, Mark J; Graham, Rondell P; Levy, Michael J; Zhu, Mojun; Billadeau, Daniel D; Adjei, Alex A; Dusetti, Nelson; Iovanna, Juan L; Bekaii-Saab, Tanios S; Ma, Wen Wee; Fernandez-Zapico, Martin E.
Afiliação
  • Hogenson TL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Xie H; Department of Gastrointestinal Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Phillips WJ; Division of Medical Oncology, Department of Oncology.
  • Toruner MD; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Li JJ; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Horn IP; Division of Medical Oncology, Department of Oncology.
  • Kennedy DJ; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Almada LL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Marks DL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Carr RM; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Toruner M; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Sigafoos AN; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Koenig-Kappes AN; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Olson RL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Tolosa EJ; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Zhang C; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Li H; Department of Pharmacology, and.
  • Doles JD; Department of Pharmacology, and.
  • Bleeker J; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA.
  • Barrett MT; Sanford Research, Oncology, Sanford Health, Sioux Falls, South Dakota, USA.
  • Boyum JH; Division of Hematology/Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Kipp BR; Department of Radiology.
  • Mahipal A; Department of Laboratory Medicine and Pathology.
  • Hubbard JM; Division of Medical Oncology, Department of Oncology.
  • Scheffler Hanson TJ; Division of Medical Oncology, Department of Oncology.
  • Petersen GM; Division of Medical Oncology, Department of Oncology.
  • Dasari S; Division of Epidemiology, Department of Quantitative Health Sciences.
  • Oberg AL; Division of Computational Biology, Department of Quantitative Health Sciences, and.
  • Truty MJ; Division of Computational Biology, Department of Quantitative Health Sciences, and.
  • Graham RP; Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA.
  • Levy MJ; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Zhu M; Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Billadeau DD; Division of Medical Oncology, Department of Oncology.
  • Adjei AA; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Dusetti N; Division of Medical Oncology, Department of Oncology.
  • Iovanna JL; Cancer Research Center of Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France.
  • Bekaii-Saab TS; Cancer Research Center of Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France.
  • Ma WW; Division of Hematology/Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Fernandez-Zapico ME; Division of Medical Oncology, Department of Oncology.
JCI Insight ; 7(22)2022 11 22.
Article em En | MEDLINE | ID: mdl-36256477
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Gastrointestinais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Gastrointestinais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article